# AMG 151 Amgen Protocol Number 20100761

> **NCT01464437** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 236 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** AMG 151
- **DRUG:** Placebo
- **DRUG:** Metformin
- **DRUG:** AMG 151
- **DRUG:** AMG 151
- **DRUG:** AMG 151
- **DRUG:** AMG 151
- **DRUG:** AMG 151

## Key facts

- **NCT ID:** NCT01464437
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2014-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464437, "AMG 151 Amgen Protocol Number 20100761". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01464437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*